Physician

Abrar H Shah, MD

According to 2025 Medicare claims, Abrar Shah, MD (NPI: 1598717324) practices cardiac electrophysiology in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is ROCHESTER GENERAL HOSPITAL (NPI: 1356412712; TIN: 160743134) and primary practice location at 14621-3001. Shah is affiliated with the Rochester Regional Health ACO, Inc. (ACO ID: A3476), participating under the MSSP model.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 400 traditional Medicare patients, billed 935 HCPCS/CPT codes, and received $82,149 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 823 prescription claims across 222 beneficiaries totaling $167,685 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 18 records totaling $499. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $170,893 to $167,685. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	484	1,601	$121,662
2016	442	1,374	$121,177
2017	458	1,426	$146,362
2018	433	1,448	$143,171
2019	418	1,483	$187,537
2020	466	1,407	$140,570
2021	454	1,470	$149,618
2022	407	1,067	$119,370
2023	410	1,207	$104,061
2024	400	935	$82,149

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	260	1,410	$170,893
2016	287	1,413	$278,143
2017	254	1,001	$231,097
2018	250	1,080	$265,734
2019	178	588	$166,505
2020	201	672	$152,143
2021	201	681	$158,158
2022	160	494	$105,292
2023	208	741	$142,685
2024	222	823	$167,685

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	33	33	$725
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	95	104	$81
93295	Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days	82	148	$27
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	128	206	$21
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	66	73	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	94	5,290	$99,558
Xarelto	Rivaroxaban	19	1,250	$22,482
Dofetilide	Dofetilide	51	3,600	$14,079
Nadolol	Nadolol	61	2,565	$2,941
Propafenone Hcl Er	Propafenone Hcl	31	1,290	$2,257

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$499	Biosense Webster, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abrar H. Shah, MD?

Tedicare shows public-source Medicare data for Abrar H. Shah, MD (NPI 1598717324), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abrar H. Shah, MD have ACO affiliation data?

Abrar H. Shah, MD is shown with ACO affiliation data for Rochester Regional Health ACO, Inc. (MSSP, ACO ID A3476).

What billing organization is linked to Abrar H. Shah, MD?

Abrar H. Shah, MD is linked to ROCHESTER GENERAL HOSPITAL (billing NPI 1356412712) in the available physician profile data.

Does Abrar H. Shah, MD have Open Payments data?

Abrar H. Shah, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.